Advertisement
Screener

LogicMark, Inc. (LGMK) Payments to Acquire in Process Research and Development

2.8 / 5 stars · 68/120 Roast Me

LogicMark, Inc. Payments to Acquire in Process Research and Development

LogicMark, Inc. (LGMK) reported Payments to Acquire in Process Research and Development of $16.68 thousand for the 6-month period ending 2024-06-30, per its 10-Q filed 2024-08-14.

Discontinued › Cash Flow › Investing Activities

us-gaap:PaymentsToAcquireInProcessResearchAndDevelopment · last filed 2024-08-14

  • LogicMark, Inc. payments to acquire in process research and development for the quarter ending 2024-06-30 was $3.10K, a 92.78% decline year-over-year.
  • LogicMark, Inc. payments to acquire in process research and development for the quarter ending 2024-03-31 was $13.58K, a 136.88% increase year-over-year.
  • LogicMark, Inc. payments to acquire in process research and development for the quarter ending 2023-12-31 was $2.36K, a 94.09% decline year-over-year.
  • LogicMark, Inc. payments to acquire in process research and development for the quarter ending 2023-09-30 was $2.38K.
  • LogicMark, Inc. payments to acquire in process research and development for fiscal 2023 was $53.43K, a 81.08% decline from fiscal 2022.
  • LogicMark, Inc. payments to acquire in process research and development for fiscal 2022 was $282.47K.
Period endPayments to Acquire in Process Research and Development 3 monthPayments to Acquire in Process Research and Development 6 monthPayments to Acquire in Process Research and Development 9 monthPayments to Acquire in Process Research and Development 12 month
2024-06-30$3.10K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14
$16.68K
10-Q · filed 2024-08-14
$19.03K
derived: sum of 3 quarters · filed 2024-08-14
$21.41K
derived: sum of 4 quarters · filed 2024-08-14
2024-03-31$13.58K
10-Q · filed 2024-05-15
$15.93K
derived: sum of 2 quarters · filed 2024-05-15
$18.31K
derived: sum of 3 quarters · filed 2024-05-15
$61.27K
derived: sum of 4 quarters · filed 2024-08-14
2023-12-31$2.36K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16
$4.73K
derived: sum of 2 quarters · filed 2024-04-16
$47.70K
derived: sum of 3 quarters · filed 2024-08-14
$53.43K
10-K · filed 2024-04-16
2023-09-30$2.38K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09
$45.34K
derived: sum of 2 quarters · filed 2024-08-14
$51.07K
10-Q · filed 2023-11-09
$90.92K
derived: sum of 4 quarters · filed 2024-08-14
2023-06-30$42.97K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14
$48.70K
10-Q · filed 2024-08-14
$88.55K
derived: sum of 3 quarters · filed 2024-08-14
2023-03-31$5.73K
10-Q · filed 2024-05-15
$45.58K
derived: sum of 2 quarters · filed 2024-05-15
2022-12-31$39.85K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16
$282.47K
10-K · filed 2024-04-16
2022-09-30$242.62K
10-Q · filed 2023-11-09

Similar stocks

Stock NameCountryMarket CapPE Ratio
Bone Biologics Corp (BBLG)United States$0.001B
ENvue Medical, Inc. (FEED)United States$0.011B
Lifeward Ltd. (LFWD)$0.021B
MILESTONE SCIENTIFIC INC. (MLSS)United States$0.036B-6.85
ALPHA PRO TECH LTD (APT)$0.052B13.63
Envoy Medical, Inc. (COCH)United States$0.056B
MYOMO, INC. (MYO)United States$0.065B-2.85
Safe Pro Group Inc. (SPAI)United States$0.090B
LAKELAND INDUSTRIES INC (LAKE)United States$0.104B-4.21
NutriBand Inc. (NTRB)United States$0.109B